Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis

BMC Cancer
Guoxuan GaoZhongtao Zhang

Abstract

The objective of this systematic review and meta-analysis was to determine the prognostic value of total tumor-infiltrating lymphocytes (TILs) and subtypes of TILs (CD4+, CD8+, and FOXP3+) in triple-negative breast cancer (TNBC). A systematic search of the MEDLINE, EMBASE, and Web of Science databases was conducted to identified eligible articles published before August 2019. Study screening, data extraction, and risk of bias assessment were performed by two independent reviewers. Risk of bias on the study level was assessed using the ROBINS I tool and Quality in Prognosis Studies (QUIPS) tool. We performed a meta-analysis to obtain a pooled estimate of the prognostic role of TILs using Review Manager 5.3. In total, 37 studies were included in the final analysis. Compared to TNBC patients with low TIL levels, TNBC patients with high TIL levels showed a higher rate of pathological complete response (pCR) to treatment (odds ratio [OR] 2.14, 95% confidence interval [CI] 1.43-3.19). With each 10% increase in percentage of TILs, patients with TNBC had an increased pCR (OR 1.09, 95% CI 1.02-1.16). Compared to TNBC patients with low TIL levels, patients with high TIL levels had better overall survival (OS; hazard ratio [HR] 0.58, 95% ...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherH D Bear
Feb 19, 2010·The Cancer Journal·Steven J Isakoff
Nov 12, 2010·The New England Journal of Medicine·William D FoulkesJorge S Reis-Filho
Oct 4, 2011·The Journal of Clinical Investigation·Hasan KorkayaMax S Wicha
Mar 17, 2012·Breast Cancer Research : BCR·Shuzhen LiuTorsten O Nielsen
Mar 1, 2011·Radiology and Oncology·Tanja OvcaricekSimona Borstnar
Feb 20, 2013·Annals of Internal Medicine·Jill A HaydenClaire Bombardier
Jan 10, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M V DieciF Andre
Mar 22, 2014·Molecular and Clinical Oncology·Miki TakenakaMasayoshi Kage
May 24, 2014·Science·Elisa Gomez Perdiguero, Frederic Geissmann
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvia AdamsSunil S Badve
Nov 2, 2014·Breast Cancer Research and Treatment·Ezzeldin M IbrahimGhieth A Kazkaz
Dec 24, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten DenkertSibylle Loibl
May 23, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M V DieciA Goubar
Oct 16, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·X YuJ Huang
Nov 26, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G PruneriG Viale
Mar 11, 2016·Breast Cancer Research and Treatment·Hirofumi MatsumotoJabed Iqbal
Oct 1, 2016·American Journal of Clinical Pathology·Xiaoxian LiRitu Aneja
Oct 14, 2016·BMJ : British Medical Journal·Jonathan Ac SterneJulian Pt Higgins
Oct 26, 2016·Journal for Immunotherapy of Cancer·Sasha E Stanton, Mary L Disis
Sep 16, 2017·Breast Cancer Research and Treatment·Roberto A Leon-FerreMatthew P Goetz
Feb 2, 2018·BioMed Research International·Bruna CerbelliLeopoldo Costarelli
Apr 14, 2018·World Journal of Clinical Oncology·Marco GalvezHenry L Gomez

❮ Previous
Next ❯

Citations

Aug 23, 2020·Animals : an Open Access Journal From MDPI·Sandra SchönigerHeinz-Adolf Schoon
Nov 17, 2020·Frontiers in Oncology·Jesús Fuentes-AntrásAlberto Ocaña
Jan 22, 2021·The Cancer Journal·Melanie MachielsPhilip Poortmans
Feb 26, 2021·Proceedings of the National Academy of Sciences of the United States of America·Ying ZhangJudy Lieberman
Feb 27, 2021·Journal of the American Society for Mass Spectrometry·Gargey YagnikMark J Lim
Mar 26, 2021·Current Oncology Reports·Elisa AgostinettoEvandro de Azambuja
May 9, 2021·Cancer Metastasis Reviews·Molly A NelsonWassana Yantasee
May 25, 2021·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Weixing LiuXiaowen Zhang
Jun 3, 2021·International Journal of Molecular Sciences·Enrico MunariLorenzo Moretta
Jun 3, 2021·International Journal of Molecular Sciences·Alyssa VitoJohn Valliant
Jun 20, 2021·International Immunopharmacology·Melina FarshbafnadiNima Rezaei
Aug 29, 2021·Journal of Magnetic Resonance Imaging : JMRI·Tiantian BianXiaohui Su
Jul 22, 2021·Journal of the National Cancer Institute·Sunil S BadveGiuseppe Viale
Sep 15, 2021·The Journal of Clinical Investigation·Xinming SuKatherine N Weilbaecher

❮ Previous
Next ❯

Software Mentioned

RevMan
ROBINS I
Review Manager
Quality In Prognosis Studies ( QUIPS )

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.